PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
26-Sep-2023 Oncopeptides announces successful price negotiations for Pepaxti in Germany Oncopeptides AB
26-Sep-2023 UCB announces approval of RYSTIGGO® (rozanolixizumab) and ZILBRYSQ® (zilucoplan) for the treatment of adult patients with generalized myasthenia gravis in Japan UCB
26-Sep-2023 XBiotech Announces Enrollment Completion of Phase I Clinical Trial for Hutrukin, a Novel Candidate Therapy for Stroke XBiotech Inc.
26-Sep-2023 Northern Gritstone and Argobio Studio back Sheffield University spin-out Crucible Therapeutics Crucible Therapeutics
26-Sep-2023 FMI Report Predicts Remarkable 7.9% CAGR, Forecasting US$5.91 Billion Valuation for Dental Imaging Equipment Market by 2030 MARKITWIRED
26-Sep-2023 Breast Imaging Market’s Exceptional 7.1% CAGR Transformation, Predicting US$8.5 Billion by 2032 | FMI Analysis Revealed MARKITWIRED
26-Sep-2023 Dupixent® (dupilumab) sBLA for Treatment of Eosinophilic Esophagitis (EoE) in Children Aged 1 to 11 Accepted for FDA Priority Review Regeneron Pharmaceuticals
26-Sep-2023 In vitro lung cell exposure systems by VITROCELL at EUROTOX 2023 VITROCELL
26-Sep-2023 Aidoc's AI Solution for Pulmonary Embolism Clinically Proven to Reduce Hospital Stay Duration and Improves Patient Access to Treatment Aidoc
26-Sep-2023 Acesion Pharma Closes Oversubscribed €45M Series B Financing Round to Advance Development of Novel Therapy for Atrial Fibrillation Acesion Pharma
26-Sep-2023 Polpharma Biologics Announces Approval of Europe’s First and Only Biosimilar for Multiple Sclerosis - Tyruko® (Natalizumab) Polpharma Biologics
26-Sep-2023 Senseonics Announces the Last Patient Completion of the 365-Day ENHANCE Pivotal Clinical Study Senseonics
26-Sep-2023 FMI’s Revealing Insights: Anemia Treatment Market on Track to Reach US$14.9 Billion by 2028, at an impressive CAGR of 6.9%. MARKITWIRED
26-Sep-2023 Biosynth extends its offering to multi-kilogram GMP peptide synthesis through the acquisition of Pepceuticals Biosynth
26-Sep-2023 Hypercalcemia Treatment Market’s Ascent: Reaching US$18.07 Billion by 2023, Aiming for US$55.07 Billion by 2033 | Reveals by FMI MARKITWIRED
26-Sep-2023 Lundbeckfonden BioCapital and +ND Capital join forces: New investment in novel hormone-free fertility treatment for women Lundbeckfonden BioCapital
26-Sep-2023 4SC: Landmark RESMAIN study data presented at the EORTC Cutaneous Lymphoma Tumour Group Annual Meeting 4SC AG
26-Sep-2023 FMI Reveals Lucrative Future for Dry Eye Syndrome Treatment Market, Projecting US$9.44 Billion Valuation by 2032 MARKITWIRED
26-Sep-2023 MC2 Therapeutics Acquires Option to Phase 2 Oral Drug Candidate for Hidradenitis Suppurativa and Other Indications MC2 Therapeutics
26-Sep-2023 Why research into early Alzheimer’s detection may help find a cure Velocity Clinical Research